The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ago,” says Alan Melcher, a clinical scientist at the Institute of Cancer ...

Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...

Durvalumab did not improve outcomes compared with cetuximab in patients with head and neck squamous cell carcinoma who are ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC).

INR:1387. city drawing BeiGene submits marketing application for tislelizumab as first-line treatment for squamous non-small cell lung cancer Novartis ophthalmic dru ...

Review of the development of chemical medicine in 2019 BeiGene submits marketing application for tislelizumab as first-line treatment for squamous non-small cell lung cancer Authoritative report: Usin ...

INR:6433. apk mb BeiGene submits marketing application for tislelizumab as first-line treatment for squamous non-small cell lung cancer List of drugs that have passed the ...

INR:5791. rummy welcome bonus 51 download Good news for type 2 diabetes! Hualing Pharmaceuticals' dorzagliatin is a success ...

INR:7360. bharat england cricket match BeiGene's PD-1 is approved for the third indication! First-line squamous non-small cell lung cancer Genes may ...

INR:7767. football legends Results of Phase III study of Tyvyt combined with chemotherapy as first-line treatment for non-squamous non-small cell lung cancer ann ...

The US Food and Drug Administration (FDA) on Friday approved nivolumab and hyaluronidase-nvhy, under the trade name Opdivo ...